Prothena Corp Plc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.84

-0.15 (-1.67%)

As of Sep 23, 2:36 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 67%

Hold 3 25%

Sell 1 8%

Price Target

Analyst Price Target +52.9% upside

Low Target $9.22

Average Target $13.52

High Target $14.31

Current Price $8.84

Current
$8.84

Target
$13.52

$9.22 $13.52 avg $14.31

Scenario Analysis

Bear Case

$9.22

4.3%

Low target

Base Case

$13.52

+52.9%

Avg target

Bull Case

$14.31

+61.9%

High target

Risk/Reward

14.4x

Highly favorable

Price in Context

52-Week High

$11.80

-25.1% from high

52-Week Low

$7.73

+14.4% from low

Target vs 52W High

$13.52

+14.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.8%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.3%